Cargando…
Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
Antibodies can swiftly provide therapeutics to target disease-related molecules discovered in genomic research. Antibody engineering techniques have been actively developed and these technological innovations have intensified the development of therapeutic antibodies. From the mid-1990’s, a series o...
Autores principales: | Suzuki, Masami, Kato, Chie, Kato, Atsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588207/ https://www.ncbi.nlm.nih.gov/pubmed/26441475 http://dx.doi.org/10.1293/tox.2015-0031 |
Ejemplares similares
-
Patient-derived xenograft (PDX) models: characteristics and points to consider for the process of establishment
por: Fujii, Etsuko, et al.
Publicado: (2020) -
rasH2 mouse: reproducibility and stability of carcinogenicity due to a
standardized production and monitoring system
por: Tsutsumi, Hideki, et al.
Publicado: (2021) -
Rapid response to a coronavirus disease 2019 (COVID-19) outbreak in a psychiatry hospital—Kanazawa City, Japan, March to April 2020
por: Kato, Hirofumi, et al.
Publicado: (2022) -
Luteal toxicity evaluation in rats
por: Taketa, Yoshikazu
Publicado: (2021) -
Anti-Thy-1 Antibody-mediated Complement-dependent Cytotoxicity is Regulated by the Distribution of Antigen, Antibody and Membrane Complement Regulatory Proteins in Rats
por: Kato, Chie, et al.
Publicado: (2013)